Refile: China-based Hutchmed to divest stake in health unit for $608 million
01/01/2025 20:09
(Changes date to Jan 1)
Jan 1 (Reuters) - Hong Kong-headquartered
biopharmaceutical company Hutchmed (China) 0013.HK on
Wednesday said it will sell stakes in a health subsidiary to GP
Health Service Capital and Shanghai Pharmaceuticals 601607.SS
for about $608 million.
(Reporting by Kumar Tanishk in Bengaluru; Editing by Cynthia
Osterman)
((Tanishk.Kumar@thomsonreuters.com;))